Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794
Author(s) -
Gregory P. Swanson,
Michael A. Hussey,
Catherine M. Tangen,
Joseph L. Chin,
Edward M. Messing,
Edith CanbyHagino,
Jeffrey D. Forman,
Ian M. Thompson,
E. David Crawford
Publication year - 2007
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2006.09.6495
Subject(s) - medicine , prostatectomy , prostate cancer , radiation therapy , prostate specific antigen , adjuvant , incidence (geometry) , urology , surgery , oncology , cancer , physics , optics
Southwest Oncology Group (SWOG) trial 8794 demonstrated that adjuvant radiation reduces the risk of biochemical (prostate-specific antigen [PSA]) treatment failure by 50% over radical prostatectomy alone. In this analysis, we stratified patients as to their preradiation PSA levels and correlated it with outcomes such as PSA treatment failure, local recurrence, and distant failure, to serve as guidelines for future research.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom